The Cleveland Clinic
The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questionnaire at the end of the first 3 months and 6 months. Study participation in the research will last about 6 months.
Inclusion Criteria 1. Adult 18-45 years old 2. Diagnosis of PCOS by usual clinical method such as by Rotterdam criteria 3. BMI \>25 kg/m2 Exclusion Criteria 1. Currently on medications that can improve glucose levels such as metformin and glucagon like receptor 1 agonists (GLP1RA) or on medications taken for the purpose of weight loss such as phentermine, topiramate, and bupropion. 2. Previously intake of above-mentioned medications and less than 3 months since last intake of metformin or weight loss medications, and less than 6 months since last intake of GLP1RA 3. Currently on insulin 4.…
Unblinded continuous glucose monitoring (CGM) system
Arctuva estimate
Verify or correct the compensation shown for this listing.